Comparison of Post-transplant Cyclophosphamide Containing Immunosuppressive Regimen with Standard Immunosuppressive Regimen in Allogeneic Stem Cell Transplantation from Matched Sibling Donor
Aim:Allogeneic stem cell transplantation (ASCT) is the only treatment that can cure most of malignant hematological diseases with the risk of some serious complications such as graft-versus-host disease (GVHD). GVHD can be got under control with post-transplant cyclophosphamide even in patients with...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayincilik
2021-12-01
|
Series: | Namık Kemal Tıp Dergisi |
Subjects: | |
Online Access: |
http://namikkemalmedj.com/archives/archive-detail/article-preview/comparison-of-post-transplant-cyclophosphamide-con/49752
|